1,1-dichloroethene increases expression ISO RGD:62281 6480464 vinylidene chloride results in increased expression of ANKRD1 mRNA CTD PMID:26682919 17beta-estradiol decreases expression ISO RGD:1348352 6480464 Estradiol results in decreased expression of ANKRD1 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions ISO RGD:1348352 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ANKRD1 mRNA CTD PMID:30165855 17beta-estradiol affects expression ISO RGD:1348352 6480464 Estradiol affects the expression of ANKRD1 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1348352 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANKRD1 mRNA CTD PMID:20106945 , PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ANKRD1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:62281 6480464 [Tetrachlorodibenzodioxin affects the methylation of ANKRD1 intron] which results in increased expression of ANKRD1 mRNA CTD PMID:33017471 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1348352 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ANKRD1 mRNA], [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of ANKRD1 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:62281 6480464 Tetrachlorodibenzodioxin affects the expression of ANKRD1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:62281 6480464 Tetrachlorodibenzodioxin results in decreased expression of ANKRD1 mRNA CTD PMID:19770486 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3,4-methylenedioxymethamphetamine increases expression ISO RGD:62281 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ANKRD1 mRNA CTD PMID:20188158 4,4'-sulfonyldiphenol increases expression ISO RGD:1348352 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANKRD1 mRNA CTD PMID:25912373 4,4'-sulfonyldiphenol increases expression ISO RGD:62281 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ANKRD1 mRNA CTD PMID:30951980 5-fluorouracil increases expression ISO RGD:1348352 6480464 Fluorouracil results in increased expression of ANKRD1 mRNA CTD PMID:17039268 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ANKRD1 mRNA CTD PMID:24780913 , PMID:25825206 aflatoxin B1 affects expression ISO RGD:1348352 6480464 Aflatoxin B1 affects the expression of ANKRD1 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1348352 6480464 Aflatoxin B1 results in increased methylation of ANKRD1 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1348352 6480464 Aflatoxin B1 results in increased expression of ANKRD1 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 decreases expression ISO RGD:62281 6480464 Aflatoxin B1 results in decreased expression of ANKRD1 mRNA CTD PMID:19770486 amitriptyline increases expression EXP 6480464 Amitriptyline results in increased expression of ANKRD1 mRNA CTD PMID:22341215 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ANKRD1 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of ANKRD1 mRNA CTD PMID:30779732 ampicillin increases expression ISO RGD:1348352 6480464 Ampicillin results in increased expression of ANKRD1 mRNA CTD PMID:21632981 andrographolide multiple interactions ISO RGD:62281 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of ANKRD1 mRNA CTD PMID:19737545 arsane increases expression ISO RGD:62281 6480464 Arsenic results in increased expression of ANKRD1 mRNA CTD PMID:23942117 arsenic atom increases expression ISO RGD:62281 6480464 Arsenic results in increased expression of ANKRD1 mRNA CTD PMID:23942117 benzo[a]pyrene increases expression ISO RGD:1348352 6480464 Benzo(a)pyrene results in increased expression of ANKRD1 mRNA CTD PMID:21871943 more ... benzo[a]pyrene increases expression ISO RGD:62281 6480464 Benzo(a)pyrene results in increased expression of ANKRD1 mRNA CTD PMID:22610609 benzo[a]pyrene decreases expression ISO RGD:1348352 6480464 Benzo(a)pyrene results in decreased expression of ANKRD1 mRNA CTD PMID:20106945 more ... benzo[a]pyrene decreases expression ISO RGD:62281 6480464 Benzo(a)pyrene results in decreased expression of ANKRD1 mRNA CTD PMID:19770486 , PMID:22228805 beta-naphthoflavone multiple interactions ISO RGD:62281 6480464 [andrographolide co-treated with beta-Naphthoflavone] results in decreased expression of ANKRD1 mRNA CTD PMID:19737545 bis(2-chloroethyl) sulfide increases expression ISO RGD:1348352 6480464 Mustard Gas results in increased expression of ANKRD1 mRNA CTD PMID:25102026 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1348352 6480464 Diethylhexyl Phthalate results in increased expression of ANKRD1 mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ANKRD1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1348352 6480464 bisphenol A results in decreased expression of ANKRD1 mRNA CTD PMID:29275510 , PMID:29718440 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ANKRD1 mRNA CTD PMID:30816183 bisphenol A increases expression ISO RGD:62281 6480464 bisphenol A results in increased expression of ANKRD1 mRNA CTD PMID:30951980 , PMID:34585602 bisphenol F increases expression ISO RGD:62281 6480464 bisphenol F results in increased expression of ANKRD1 mRNA CTD PMID:30951980 bleomycin A2 increases expression ISO RGD:62281 6480464 Bleomycin results in increased expression of ANKRD1 mRNA CTD PMID:26345256 Botulinum toxin type A increases expression EXP 6480464 Botulinum Toxins, Type A results in increased expression of ANKRD1 mRNA CTD PMID:18603602 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of ANKRD1 mRNA CTD PMID:32479839 butanal increases expression ISO RGD:1348352 6480464 butyraldehyde results in increased expression of ANKRD1 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:1348352 6480464 Cadmium results in increased expression of ANKRD1 mRNA CTD PMID:21172416 , PMID:33559965 cadmium dichloride decreases expression ISO RGD:1348352 6480464 Cadmium Chloride results in decreased expression of ANKRD1 mRNA CTD PMID:26314618 cadmium sulfate increases expression ISO RGD:1348352 6480464 cadmium sulfate results in increased expression of ANKRD1 mRNA CTD PMID:12064557 more ... carbon nanotube increases expression ISO RGD:62281 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects response to substance ISO RGD:1348352 6480464 ANKRD1 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 chlordecone decreases expression ISO RGD:62281 6480464 Chlordecone results in decreased expression of ANKRD1 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:62281 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANKRD1 mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:62281 6480464 Cisplatin results in increased expression of ANKRD1 mRNA CTD PMID:21151649 cisplatin decreases expression ISO RGD:1348352 6480464 Cisplatin results in decreased expression of ANKRD1 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1348352 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of ANKRD1 mRNA CTD PMID:27392435 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of ANKRD1 mRNA CTD PMID:22023808 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ANKRD1 mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:1348352 6480464 cobaltous chloride results in decreased expression of ANKRD1 mRNA CTD PMID:19320972 copper(II) chloride increases expression ISO RGD:1348352 6480464 cupric chloride results in increased expression of ANKRD1 mRNA CTD PMID:17211630 copper(II) sulfate increases expression ISO RGD:1348352 6480464 Copper Sulfate results in increased expression of ANKRD1 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:62281 6480464 Cyclosporine results in decreased expression of ANKRD1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1348352 6480464 Cyclosporine results in decreased expression of ANKRD1 mRNA CTD PMID:27989131 cyclosporin A increases expression ISO RGD:1348352 6480464 Cyclosporine results in increased expression of ANKRD1 mRNA CTD PMID:25562108 cylindrospermopsin increases expression ISO RGD:1348352 6480464 cylindrospermopsin results in increased expression of ANKRD1 mRNA CTD PMID:24921660 daunorubicin decreases expression EXP 6480464 Daunorubicin results in decreased expression of ANKRD1 mRNA CTD PMID:9278441 dexamethasone decreases expression ISO RGD:62281 6480464 Dexamethasone results in decreased expression of ANKRD1 mRNA CTD PMID:22733784 dibutyl phthalate increases expression ISO RGD:62281 6480464 Dibutyl Phthalate results in increased expression of ANKRD1 mRNA CTD PMID:21266533 dimethylarsinic acid multiple interactions ISO RGD:62281 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA CTD PMID:34876320 dimethylarsinous acid increases expression ISO RGD:1348352 6480464 dimethylarsinous acid results in increased expression of ANKRD1 mRNA CTD PMID:23876855 dioxygen decreases expression ISO RGD:1348352 6480464 Oxygen deficiency results in decreased expression of ANKRD1 mRNA CTD PMID:24236059 dioxygen multiple interactions ISO RGD:62281 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ANKRD1 mRNA CTD PMID:30529165 diquat increases expression ISO RGD:1348352 6480464 Diquat results in increased expression of ANKRD1 mRNA CTD PMID:21172416 dorsomorphin multiple interactions ISO RGD:1348352 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO RGD:62281 6480464 CYP2J2 protein inhibits the reaction [Doxorubicin results in increased activity of ANKRD1 protein] CTD PMID:19429816 doxorubicin increases expression ISO RGD:1348352 6480464 Doxorubicin results in increased expression of ANKRD1 mRNA CTD PMID:29803840 doxorubicin affects localization EXP 6480464 Doxorubicin affects the localization of ANKRD1 protein CTD PMID:22532871 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ANKRD1 mRNA, Doxorubicin results in decreased expression of ANKRD1 protein CTD PMID:22532871 , PMID:9278441 doxorubicin decreases expression ISO RGD:62281 6480464 Doxorubicin results in decreased expression of ANKRD1 mRNA CTD PMID:17531194 doxorubicin increases expression ISO RGD:62281 6480464 Doxorubicin results in increased expression of ANKRD1 mRNA, Doxorubicin results in increased expression of ANKRD1 protein CTD PMID:16243910 , PMID:19429816 Echimidine decreases expression EXP 6480464 echimidine results in decreased expression of ANKRD1 mRNA CTD PMID:34185104 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ANKRD1 mRNA CTD PMID:29391264 ethanol decreases expression ISO RGD:1348352 6480464 Ethanol results in decreased expression of ANKRD1 mRNA CTD PMID:31059573 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of ANKRD1 mRNA CTD PMID:30307764 folic acid increases expression ISO RGD:1348352 6480464 Folic Acid results in increased expression of ANKRD1 mRNA CTD PMID:17868486 folic acid multiple interactions ISO RGD:62281 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANKRD1 mRNA CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1348352 6480464 Formaldehyde results in decreased expression of ANKRD1 mRNA CTD PMID:28937961 geldanamycin increases expression ISO RGD:1348352 6480464 geldanamycin results in increased expression of ANKRD1 mRNA CTD PMID:26705709 gemcitabine increases expression ISO RGD:1348352 6480464 gemcitabine results in increased expression of ANKRD1 mRNA CTD PMID:17039268 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ANKRD1 mRNA CTD PMID:33387578 Heliotrine decreases expression EXP 6480464 heliotrine results in decreased expression of ANKRD1 mRNA CTD PMID:34185104 hydrogen peroxide affects expression ISO RGD:1348352 6480464 Hydrogen Peroxide affects the expression of ANKRD1 mRNA CTD PMID:20044591 L-methionine multiple interactions ISO RGD:62281 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ANKRD1 mRNA CTD PMID:20938992 leflunomide increases expression ISO RGD:1348352 6480464 leflunomide results in increased expression of ANKRD1 mRNA CTD PMID:28988120 Licochalcone B increases expression ISO RGD:1348352 6480464 licochalcone B results in increased expression of ANKRD1 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO RGD:1348352 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ANKRD1 mRNA CTD PMID:26667767 mercury dibromide increases expression ISO RGD:1348352 6480464 mercuric bromide results in increased expression of ANKRD1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1348352 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 methylarsonic acid multiple interactions ISO RGD:62281 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA CTD PMID:34876320 methylisothiazolinone increases expression ISO RGD:1348352 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of ANKRD1 mRNA CTD PMID:31629900 methylmercury chloride decreases expression ISO RGD:1348352 6480464 methylmercuric chloride results in decreased expression of ANKRD1 mRNA CTD PMID:34089799 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of ANKRD1 mRNA CTD PMID:21515302 nickel sulfate decreases expression ISO RGD:1348352 6480464 nickel sulfate results in decreased expression of ANKRD1 mRNA CTD PMID:22714537 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of ANKRD1 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO RGD:1348352 6480464 methyleugenol results in decreased expression of ANKRD1 mRNA CTD PMID:32234424 p-chloromercuribenzoic acid increases expression ISO RGD:1348352 6480464 p-Chloromercuribenzoic Acid results in increased expression of ANKRD1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1348352 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO RGD:1348352 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1348352 6480464 panobinostat results in increased expression of ANKRD1 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:62281 6480464 Acetaminophen affects the expression of ANKRD1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ANKRD1 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1348352 6480464 Acetaminophen results in increased expression of ANKRD1 mRNA CTD PMID:29067470 perfluorooctanoic acid decreases expression ISO RGD:1348352 6480464 perfluorooctanoic acid results in decreased expression of ANKRD1 mRNA CTD PMID:32588087 phenobarbital affects expression ISO RGD:1348352 6480464 Phenobarbital affects the expression of ANKRD1 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:1348352 6480464 Phenylmercuric Acetate results in increased expression of ANKRD1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1348352 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1348352 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ANKRD1 mRNA CTD PMID:19710929 Platyphylline decreases expression EXP 6480464 platyphylline results in decreased expression of ANKRD1 mRNA CTD PMID:34185104 propanal increases expression ISO RGD:1348352 6480464 propionaldehyde results in increased expression of ANKRD1 mRNA CTD PMID:26079696 quinolin-8-ol increases expression ISO RGD:1348352 6480464 Oxyquinoline results in increased expression of ANKRD1 mRNA CTD PMID:21632981 raloxifene multiple interactions ISO RGD:1348352 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in increased expression of ANKRD1 mRNA CTD PMID:19059307 resveratrol multiple interactions ISO RGD:1348352 6480464 [Lipopolysaccharides co-treated with resveratrol] results in decreased expression of ANKRD1 mRNA CTD PMID:26667767 rotenone increases expression ISO RGD:62281 6480464 Rotenone results in increased expression of ANKRD1 mRNA CTD PMID:32937126 SB 431542 multiple interactions ISO RGD:1348352 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine decreases expression EXP 6480464 senecionine results in decreased expression of ANKRD1 mRNA CTD PMID:34185104 silicon dioxide increases expression ISO RGD:1348352 6480464 Silicon Dioxide analog results in increased expression of ANKRD1 mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:1348352 6480464 Silver results in increased expression of ANKRD1 mRNA CTD PMID:26014281 silver(0) increases expression ISO RGD:1348352 6480464 Silver results in increased expression of ANKRD1 mRNA CTD PMID:26014281 sodium arsenate multiple interactions ISO RGD:62281 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:62281 6480464 sodium arsenite results in decreased expression of ANKRD1 mRNA CTD PMID:16014739 sodium arsenite multiple interactions ISO RGD:62281 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of ANKRD1 mRNA CTD PMID:34876320 sodium arsenite increases expression ISO RGD:1348352 6480464 sodium arsenite results in increased expression of ANKRD1 mRNA CTD PMID:29301061 stigmasterol multiple interactions ISO RGD:62281 6480464 [NR1H4 gene mutant form affects the susceptibility to Stigmasterol] which results in decreased expression of ANKRD1 mRNA CTD PMID:30245210 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ANKRD1 mRNA CTD PMID:16684804 streptozocin multiple interactions EXP 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of ANKRD1 mRNA] CTD PMID:16684804 sunitinib decreases expression ISO RGD:1348352 6480464 Sunitinib results in decreased expression of ANKRD1 mRNA CTD PMID:31533062 tacrolimus hydrate increases expression ISO RGD:62281 6480464 Tacrolimus results in increased expression of ANKRD1 mRNA CTD PMID:29362864 tamoxifen multiple interactions ISO RGD:1348352 6480464 [Tamoxifen co-treated with ESR2 protein] results in increased expression of ANKRD1 mRNA CTD PMID:19059307 temozolomide affects response to substance ISO RGD:1348352 6480464 ANKRD1 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 temozolomide increases expression ISO RGD:1348352 6480464 Temozolomide results in increased expression of ANKRD1 mRNA CTD PMID:31758290 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ANKRD1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:62281 6480464 titanium dioxide results in increased expression of ANKRD1 mRNA CTD PMID:23409001 titanium dioxide decreases expression ISO RGD:62281 6480464 titanium dioxide results in decreased expression of ANKRD1 mRNA CTD PMID:23557971 triadimefon decreases expression ISO RGD:1348352 6480464 triadimefon results in decreased expression of ANKRD1 mRNA CTD PMID:26705709 trichloroethene decreases expression ISO RGD:62281 6480464 Trichloroethylene results in decreased expression of ANKRD1 mRNA CTD PMID:25055964 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of ANKRD1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1348352 6480464 trichostatin A results in increased expression of ANKRD1 mRNA CTD PMID:24935251 more ... trichostatin A multiple interactions ISO RGD:1348352 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1348352 6480464 tris(2-butoxyethyl) phosphate affects the expression of ANKRD1 mRNA CTD PMID:29024780 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of ANKRD1 mRNA CTD PMID:21515302 tunicamycin increases expression ISO RGD:1348352 6480464 Tunicamycin results in increased expression of ANKRD1 mRNA CTD PMID:29453283 urethane decreases expression ISO RGD:1348352 6480464 Urethane results in decreased expression of ANKRD1 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:62281 6480464 Valproic Acid results in decreased expression of ANKRD1 mRNA CTD PMID:15799026 valproic acid multiple interactions ISO RGD:1348352 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ANKRD1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1348352 6480464 Valproic Acid results in increased expression of ANKRD1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1348352 6480464 Valproic Acid affects the expression of ANKRD1 mRNA CTD PMID:25979313 vanadyl sulfate multiple interactions EXP 6480464 vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of ANKRD1 mRNA] CTD PMID:16684804 verteporfin multiple interactions ISO RGD:1348352 6480464 verteporfin inhibits the reaction [YAP1 protein results in increased expression of ANKRD1 mRNA] CTD PMID:29725256 verteporfin multiple interactions ISO RGD:62281 6480464 Verteporfin inhibits the reaction [1 more ... CTD PMID:29893953 verteporfin decreases expression ISO RGD:1348352 6480464 verteporfin results in decreased expression of ANKRD1 mRNA CTD PMID:29725256 vorinostat increases expression ISO RGD:1348352 6480464 vorinostat results in increased expression of ANKRD1 mRNA CTD PMID:26272509